{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:00:02Z","timestamp":1790413202591,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Shanghai Pujiang Program","award":["17PJ1408700"],"award-info":[{"award-number":["17PJ1408700"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703757"],"award-info":[{"award-number":["81703757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.tips.2018.03.008","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T21:58:40Z","timestamp":1524002320000},"page":"648-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":177,"title":["Targeting Wnt\/\u03b2-Catenin Signaling for Cancer Immunotherapy"],"prefix":"10.1016","volume":"39","author":[{"given":"Bojun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Henning","family":"Kalland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xisong","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2018.03.008_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2018.03.008_bib0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2018.03.008_bib0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tips.2018.03.008_bib0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/1078-0432.CCR-16-1163","article-title":"PD-1\/PD-L1 blockade enhances T-cell activity and antitumor efficacy of imatinib in gastrointestinal stromal tumors","volume":"23","author":"Seifert","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tips.2018.03.008_bib0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.tips.2018.03.008_bib0030","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2018.03.008_bib0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2018.03.008_bib0040","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2018.03.008_bib0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","article-title":"T-cell invigoration to tumour burden ratio associated with anti-PD-1 response","volume":"545","author":"Huang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tips.2018.03.008_bib0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1126\/scitranslmed.aak9670","article-title":"Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade","volume":"9","author":"Schmittnaegel","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2018.03.008_bib0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nm.4219","article-title":"Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors","volume":"23","author":"Steinhart","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2018.03.008_bib0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tips.2018.03.008_bib0065","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2018.03.008_bib0070","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1158\/0008-5472.CAN-16-2387","article-title":"Beta-catenin mutations: insights into the APC pathway and the power of genetics","volume":"76","author":"Morin","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2018.03.008_bib0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature22334","article-title":"A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma","volume":"545","author":"Tammela","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tips.2018.03.008_bib0080","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.e14608","article-title":"RNAi-mediated beta-catenin inhibition to promote T-cell infiltration and antitumor activity in combination with immune checkpoint blockade","volume":"35","author":"Ganesh","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tips.2018.03.008_bib0085","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.3004","article-title":"Correlation of WNT\/beta-catenin pathway activation with immune exclusion across most human cancers","volume":"34","author":"Luke","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tips.2018.03.008_bib0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/j.1460-2075.1991.tb07928.x","article-title":"Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box","volume":"10","author":"Van","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.tips.2018.03.008_bib0095","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm.1982","article-title":"Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells","volume":"15","author":"Gattinoni","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2018.03.008_bib0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ncb0303-179","article-title":"Armadillo\/beta-catenin signals in the nucleus - proof beyond a reasonable doubt?","volume":"5","author":"Bienz","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tips.2018.03.008_bib0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc.2017.117","article-title":"Impact of oncogenic pathways on evasion of antitumour immune responses","volume":"18","author":"Spranger","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tips.2018.03.008_bib0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2018.03.008_bib0115","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2018.03.008_bib0120","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4049\/jimmunol.1402453","article-title":"Beta-catenin signaling drives differentiation and proinflammatory function of IRF8-dependent dendritic cells","volume":"194","author":"Cohen","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0125","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1073\/pnas.1414167112","article-title":"Beta-catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10","volume":"112","author":"Fu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2018.03.008_bib0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1189\/jlb.0613330","article-title":"Beta-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8(+) T cells","volume":"95","author":"Liang","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.tips.2018.03.008_bib0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2011.07.002","article-title":"The role of retinoic acid in tolerance and immunity","volume":"35","author":"Hall","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2018.03.008_bib0140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1158\/0008-5472.CAN-14-2377","article-title":"Beta-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cells","volume":"75","author":"Hong","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2018.03.008_bib0145","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1115941","article-title":"Deletion of LRP5 and LRP6 in dendritic cells enhances antitumor immunity","volume":"5","author":"Hong","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.tips.2018.03.008_bib0150","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.4049\/jimmunol.1402691","article-title":"Canonical wnt signaling in dendritic cells regulates Th1\/Th17 responses and suppresses autoimmune neuroinflammation","volume":"194","author":"Suryawanshi","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0155","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Diamond","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2018.03.008_bib0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tips.2018.03.008_bib0165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4049\/jimmunol.1401238","article-title":"A critical role for the regulated wnt-myc pathway in naive T cell survival","volume":"194","author":"Wong","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0170","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.4049\/jimmunol.1303417","article-title":"T cell factor 1 represses CD8+ effector T cell formation and function","volume":"193","author":"Tiemessen","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0175","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4049\/jimmunol.1700595","article-title":"Differential requirements for Tcf1 long isoforms in CD8+ and CD4+ T cell responses to acute viral infection","volume":"199","author":"Gullicksrud","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.immuni.2010.08.002","article-title":"Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1","volume":"33","author":"Zhou","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2018.03.008_bib0185","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.4049\/jimmunol.1400465","article-title":"Differences in the transduction of canonical Wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacity","volume":"193","author":"Boudousquie","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0190","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2018.03.008_bib0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.aad2035","article-title":"Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes","volume":"352","author":"Mackay","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.tips.2018.03.008_bib0200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tips.2018.03.008_bib0205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","article-title":"Primary antitumor immune response mediated by CD4(+) T cells","volume":"22","author":"Corthay","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2018.03.008_bib0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0215","first-page":"922","article-title":"Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function","volume":"8","author":"Giuntoli","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tips.2018.03.008_bib0220","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.4049\/jimmunol.1700247","article-title":"Wnt\/beta-catenin signaling induces integrin alpha4beta1 in T cells and promotes a progressive neuroinflammatory disease in mice","volume":"199","author":"Sorcini","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0225","doi-asserted-by":"crossref","first-page":"15168","DOI":"10.18632\/oncotarget.14834","article-title":"Colorectal cancer cells suppress CD4(+) T cells immunity through canonical Wnt signaling","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tips.2018.03.008_bib0230","doi-asserted-by":"crossref","first-page":"E1168","DOI":"10.1073\/pnas.1609905114","article-title":"Endothelial Wnt\/beta-catenin signaling reduces immune cell infiltration in multiple sclerosis","volume":"114","author":"Lengfeld","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2018.03.008_bib0235","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ni.2897","article-title":"TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells","volume":"15","author":"Steinke","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0240","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ni.1762","article-title":"T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma","volume":"10","author":"Yu","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0245","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007607","article-title":"Beta-catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells","volume":"6","author":"Keerthivasan","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2018.03.008_bib0250","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.immuni.2011.09.019","article-title":"Th17 cells are long lived and retain a stem cell-like molecular signature","volume":"35","author":"Muranski","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2018.03.008_bib0255","doi-asserted-by":"crossref","first-page":"90547","DOI":"10.1172\/jci.insight.90547","article-title":"Beta-catenin and PI3Kdelta inhibition expands precursor Th17 cells with heightened stemness and antitumor activity","volume":"2","author":"Majchrzak","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.tips.2018.03.008_bib0260","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000448","article-title":"The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells","volume":"2","author":"Paulos","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2018.03.008_bib0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.tips.2018.03.008_bib0270","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2018.03.008_bib0275","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0280","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood-2012-09-456988","article-title":"Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg","volume":"122","author":"Baur","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tips.2018.03.008_bib0285","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nm1707","article-title":"Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells","volume":"14","author":"Ding","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2018.03.008_bib0290","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature23665","article-title":"Homeostatic control of metabolic and functional fitness of Treg cells by LKB1 signalling","volume":"548","author":"Yang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tips.2018.03.008_bib0295","doi-asserted-by":"crossref","first-page":"6235614","DOI":"10.1155\/2016\/6235614","article-title":"Blockade of Wnt\/beta-catenin pathway aggravated silica-induced lung inflammation through Tregs regulation on Th immune responses","volume":"2016","author":"Dai","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.tips.2018.03.008_bib0300","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s00018-009-9153-z","article-title":"Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer","volume":"66","author":"Dominguez","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tips.2018.03.008_bib0305","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ni.3083","article-title":"Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo","volume":"16","author":"Ulges","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0310","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature05478","article-title":"Foxp3 occupancy and regulation of key target genes during T-cell stimulation","volume":"445","author":"Marson","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.tips.2018.03.008_bib0315","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.immuni.2013.07.019","article-title":"Canonical Wnt signaling negatively modulates regulatory T cell function","volume":"39","author":"van Loosdregt","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2018.03.008_bib0320","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clim.2008.12.008","article-title":"IL-1 beta and IL-2 convert human Treg into T(H)17 cells","volume":"131","author":"Deknuydt","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0325","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2018.03.008_bib0330","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/0008-5472.CAN-03-3259","article-title":"PD-L1\/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8(+) T cells","volume":"64","author":"Blank","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2018.03.008_bib0335","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.tips.2018.03.008_bib0340","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tips.2018.03.008_bib0345","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.molimm.2006.08.006","article-title":"Activating transcription factor 3 (ATF3) represses the expression of CCL4 in murine macrophages","volume":"44","author":"Khuu","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.tips.2018.03.008_bib0350","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","article-title":"Metastatic latency and immune evasion through autocrine inhibition of WNT","volume":"165","author":"Malladi","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tips.2018.03.008_bib0355","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for combining targeted and conventional cancer therapy with immunotherapy","volume":"17","author":"Gotwals","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tips.2018.03.008_bib0360","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature21676","article-title":"Effective combinatorial immunotherapy for castration-resistant prostate cancer","volume":"543","author":"Lu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tips.2018.03.008_bib0365","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S1470-2045(16)30366-7","article-title":"Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial","volume":"17","author":"Hodi","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tips.2018.03.008_bib0370","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tips.2018.03.008_bib0375","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ncb2048","article-title":"Wnt activity defines colon cancer stem cells and is regulated by the microenvironment","volume":"12","author":"Vermeulen","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tips.2018.03.008_bib0380","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1073\/pnas.1621346114","article-title":"Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist","volume":"114","author":"Moon","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2018.03.008_bib0385","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/1078-0432.CCR-14-3081","article-title":"Tankyrase inhibition blocks Wnt\/beta-catenin pathway and reverts resistance to PI3K and AKT inhibitors in the treatment of colorectal cancer","volume":"22","author":"Arques","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tips.2018.03.008_bib0390","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cell.2012.05.002","article-title":"Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex","volume":"149","author":"Li","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tips.2018.03.008_bib0395","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1073\/pnas.1604520113","article-title":"Axitinib blocks Wnt\/beta-catenin signaling and directs asymmetric cell division in cancer","volume":"113","author":"Qu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2018.03.008_bib0400","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nchembio.2510","article-title":"Small molecule promotes beta-catenin citrullination and inhibits Wnt signaling in cancer","volume":"14","author":"Qu","year":"2018","journal-title":"Nat. Chem. Biol."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614718300609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614718300609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T22:16:31Z","timestamp":1604182591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614718300609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0165614718300609"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2018.03.008","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Wnt\/\u03b2-Catenin Signaling for Cancer Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2018.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}